use of escitalopram or a pharmaceutically acceptable salt of the same use of escitalopram or a pharmaceutically acceptable salt thereof in combination with one or more antipsychotic compounds, pharmaceutical composition, method for improving cognition in a condition where the cognitive process is impaired, and use of escitalopram

摘要

USE OF SCITALOPRAM OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, USE OF ESCITALOPRAM OR A PHARMACEUTICALLY ACCEPTABLE SALT IN COMBINATION WITH ONE OR MORE ANTIPSYCHOTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, IT IS A HARMFUL HARMFUL AGAINST A HARMFUL HARMFUL HARMFUL HARMFUL HARMFUL HARMFUL HARMFUL HARMFUL HARMFUL AGAINST A HARMFUL HARMFUL HARMFUL HARMFUL HARMFORE USE OF ESCITALOPRAM The present invention relates to the use of the compound escitalopram (name INN), that is (5) - 1- [3 - (dimethylamino) propyl] -1 - (4-fluorophenyl) -, 3 3-dihydro-5 -isobenzofuranearbonitrile, or a pharmaceutically acceptable salt thereof for the preparation of a medication to improve cognition in a condition where the cognitive process is slowed.